Healthcare Of Ontario Pension Plan Trust Fund Arvinas, Inc. Transaction History

Healthcare Of Ontario Pension Plan Trust Fund

$40.7 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$24.46 - $40.4 $330,210 - $545,400	-13,500 Reduced 18.24%	60,500 $1.61 Million
Q4 2023 Mar 21, 2024	BUY	$14.19 - $42.33 $1.05 Million - $3.13 Million	74,000 New	74,000 $3.05 Million
Q4 2022 Feb 13, 2023	BUY	$32.47 - $57.24 $990,335 - $1.75 Million	30,500 Added 406.67%	38,000 $1.3 Million
Q3 2022 Nov 14, 2022	SELL	$41.87 - $57.99 $1.57 Million - $2.18 Million	-37,600 Reduced 83.37%	7,500 $334,000
Q2 2022 Aug 11, 2022	BUY	$36.01 - $74.24 $1.62 Million - $3.35 Million	45,100 New	45,100 $1.9 Million
Q3 2021 Nov 10, 2021	SELL	$73.2 - $107.87 $168,360 - $248,101	-2,300 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$60.45 - $84.26 $4.81 Million - $6.7 Million	-79,500 Reduced 97.19%	2,300 $177,000
Q1 2021 May 13, 2021	BUY	$58.19 - $91.37 $1.44 Million - $2.27 Million	24,800 Added 43.51%	81,800 $5.41 Million
Q4 2020 Feb 12, 2021	BUY	$20.19 - $84.93 $1.15 Million - $4.84 Million	57,000 New	57,000 $4.84 Million

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

Vanguard Group Inc Valley Forge, PA

7.01M
Shares

$134 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

6.73M
Shares

$128 Million
7.19% of portfolio
Black Rock Inc. New York, NY

6.26M
Shares

$119 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.85M
Shares

$73.5 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

2.78M
Shares

$53.1 Million
1.09% of portfolio

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.

Account